International experience of vedolizumab in primary sclerosis cholangitis and inflammatory bowel disease

Conference contribution


Publication Details

Author(s): Williamson K, Lytvyak E, Kremer A, De Krijger M, Trivedi P, Estes D, Yu L, Pratt D, De Vries A, Yimam KK, Daretti L, Liu CH, Bowlus C, Vetter M, Marschall HU, Montano-Loza A, Chapman RWG, Marzioni M, Keshav S, Ponsioen C, Hirschfield G, Levy C
Publisher: ELSEVIER SCIENCE BV
Publishing place: AMSTERDAM
Publication year: 2018
Conference Proceedings Title: JOURNAL OF HEPATOLOGY
Pages range: S74-S75
ISSN: 0168-8278


FAU Authors / FAU Editors

Kremer, Andreas PD Dr.
Medizinische Klinik 1 - Gastroenterologie, Pneumologie und Endokrinologie
Vetter, Marcel Dr. med.
Medizinische Klinik 1 - Gastroenterologie, Pneumologie und Endokrinologie


External institutions
Academic Medical Centre / Academisch Medisch Centrum (AMC)
Azienda Ospedaliero Universitaria Ospedali Riuniti Ancona
California Pacific Medical Center
Erasmus University Medical Center
Massachusetts General Hospital
University of Alberta
University of Birmingham
University of California Davis (UCDAVIS)
University of Gothenburg / Göteborgs universitet
University of Miami
University of Oxford
University of Washington


How to cite

APA:
Williamson, K., Lytvyak, E., Kremer, A., De Krijger, M., Trivedi, P., Estes, D.,... Levy, C. (2018). International experience of vedolizumab in primary sclerosis cholangitis and inflammatory bowel disease. In JOURNAL OF HEPATOLOGY (pp. S74-S75). Paris, FR: AMSTERDAM: ELSEVIER SCIENCE BV.

MLA:
Williamson, K., et al. "International experience of vedolizumab in primary sclerosis cholangitis and inflammatory bowel disease." Proceedings of the International Liver Congress (ILC), Paris AMSTERDAM: ELSEVIER SCIENCE BV, 2018. S74-S75.

BibTeX: 

Last updated on 2019-27-03 at 09:23